Erratum

Erratum 554 G. Mugnai et al. prevalence, management, and correlation with prognosis. Heart Rhythm patients with Brugada syndrome and an implantable cardioverter defibrillator to 2014;11:259–65. prevent inappropriate shock therapy. Heart Rhythm 2016;13:1455–9. 3. Pappone C, Radinovic A, Manguso F, Vicedomini G, Sala S, Sacco FM et al. New- 10. Ciconte G, de Asmundis C, Sieira J, Conte G, Di Giovanni G, Mugnai G et al. onset atrial fibrillation as first clinical manifestation of latent Brugada syndrome: Single 3-minute freeze for second-generation cryoballoon ablation: one-year fol- prevalence and clinical significance. Eur Heart J 2009;30:2985–92. low up after pulmonary vein isolation. Heart Rhythm 2015;12:673–80. 4. Kusano KF, Taniyama M, Nakamura K, Miura D, Banba K, Nagase S et al. Atrial 11. Di Giovanni G, Wauters K, Chierchia GB, Sieira J, Levinstein M, Conte G et al. fibrillation in patients with Brugada syndrome relationships of gene mutation, One-year follow-up after single procedure Cryoballoon ablation: a comparison electrophysiology, and clinical backgrounds. J Am Coll Cardiol 2008;51:1169–75. between the first and second generation balloon. J Cardiovasc Electrophysiol 5. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D et al. 2014;25:834–9. Brugada syndrome; report of the second consensus conference: endorsed by the 12. Yap YG, Behr ER, Camm AJ. Drug-induced Brugada syndrome. Europace Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2009;11:989–94. 2005;111:659–70. 13. Morita H, Kusano-Fukushima K, Nagase S, Fujimoto Y, Hisamatsu K, Fujio H et al. 6. Camm AJ, Lip GY, De Caterina R, Savelieva D, Atar D, Hohnloser SH et al; ESC Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome. JAm Committee for Practice Guidelines-CPG. 2012 focused update of the ESC Coll Cardiol 2002;40:1437–44. Guidelines for the management of atrial fibrillation: an update of the 2010 14. Kofune M, Watanabe I, Ohkubo K, Ashino S, Okumura Y, Nagashima K et al. ESC Guidelines for the management of atrial fibrillation – developed with the Abnormal atrial repolarization and depolarization contribute to the inducibility special contribution of the European Heart Rhythm Association. Europace of atrial fibrillation in Brugada syndrome. Int Heart J 2010;51:159–65. 2012;14:1385–413. 15. Chen Q, Kirsch GE, Zhang D, Brugada R, Brugada J, Brugada P et al. Genetic 7. Yamada T, Yoshida Y, Tsuboi N, Murakami Y, Okada T, McElderry HT et al. basis and molecular mechanism for idiopathic ventricular fibrillation. Nature Efficacy of pulmonary vein isolation in paroxysmal atrial fibrillation patients with 1998;392:293–6. a Brugada electrocardiogram. Circ J 2008;72:281–6. 16. Calloe K, Cordeiro JM, Di Diego JM, Hansen RS, Grunnet M, Olesen SP et al.A 8. Conte G, Chierchia GB, Wauters K, De Asmundis C, Sarkozy A, Levinstein M transient outward potassium current activator recapitulates the electrocardio- et al. Pulmonary vein isolation in patients with Brugada syndrome and atrial fibril- graphic manifestations of Brugada syndrome. Cardiovasc Res 2009;81:686–94. lation: a 2-year follow-up. Europace 2014;16:528–32. 17. Miyazaki S, Taniguchi H, Kusa S, Komatsu Y, Ichihara N, Takagi T et al. Catheter 9. Kitamura T, Fukamizu S, Kawamura I, Hojo R, Aoyama Y, Komiyama K et al. ablation of atrial tachyarrhythmias causing inappropriate implantable Long-term efficacy of catheter ablation for paroxysmal atrial fibrillation in cardioverter-defibrillator shocks. Europace 2015;17:289–94. Erratum doi:10.1093/europace/euy033 .................................................................................................................................................... Erratum to: Use of leadless pacemakers in Europe: results of the European Heart Rhythm Association survey [Europace 2018;20:555–9]. This paper has been corrected online and in print to add an acknowledgement: ‘This document is supported by Medtronic in the form of an educational grant. The content has not been influenced in any way by its sponsor.’ The Publisher apologises for this error. Published on behalf of the European Society of Cardiology. All rights reserved.V The Author(s) 2018. For permissions, please email: journals.permissions@oup.com. Downloaded from https://academic.oup.com/europace/article-abstract/20/3/554/4862498 by Ed 'DeepDyve' Gillespie user on 16 March 2018 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Europace Oxford University Press

Erratum

Europace , Volume 20 (3) – Mar 1, 2018
Free
1 page

Loading next page...
1 Page
 
/lp/ou_press/erratum-dpLsAqdAyx
Publisher
Oxford University Press
Copyright
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.
ISSN
1099-5129
eISSN
1532-2092
D.O.I.
10.1093/europace/euy033
Publisher site
See Article on Publisher Site

Abstract

554 G. Mugnai et al. prevalence, management, and correlation with prognosis. Heart Rhythm patients with Brugada syndrome and an implantable cardioverter defibrillator to 2014;11:259–65. prevent inappropriate shock therapy. Heart Rhythm 2016;13:1455–9. 3. Pappone C, Radinovic A, Manguso F, Vicedomini G, Sala S, Sacco FM et al. New- 10. Ciconte G, de Asmundis C, Sieira J, Conte G, Di Giovanni G, Mugnai G et al. onset atrial fibrillation as first clinical manifestation of latent Brugada syndrome: Single 3-minute freeze for second-generation cryoballoon ablation: one-year fol- prevalence and clinical significance. Eur Heart J 2009;30:2985–92. low up after pulmonary vein isolation. Heart Rhythm 2015;12:673–80. 4. Kusano KF, Taniyama M, Nakamura K, Miura D, Banba K, Nagase S et al. Atrial 11. Di Giovanni G, Wauters K, Chierchia GB, Sieira J, Levinstein M, Conte G et al. fibrillation in patients with Brugada syndrome relationships of gene mutation, One-year follow-up after single procedure Cryoballoon ablation: a comparison electrophysiology, and clinical backgrounds. J Am Coll Cardiol 2008;51:1169–75. between the first and second generation balloon. J Cardiovasc Electrophysiol 5. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D et al. 2014;25:834–9. Brugada syndrome; report of the second consensus conference: endorsed by the 12. Yap YG, Behr ER, Camm AJ. Drug-induced Brugada syndrome. Europace Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2009;11:989–94. 2005;111:659–70. 13. Morita H, Kusano-Fukushima K, Nagase S, Fujimoto Y, Hisamatsu K, Fujio H et al. 6. Camm AJ, Lip GY, De Caterina R, Savelieva D, Atar D, Hohnloser SH et al; ESC Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome. JAm Committee for Practice Guidelines-CPG. 2012 focused update of the ESC Coll Cardiol 2002;40:1437–44. Guidelines for the management of atrial fibrillation: an update of the 2010 14. Kofune M, Watanabe I, Ohkubo K, Ashino S, Okumura Y, Nagashima K et al. ESC Guidelines for the management of atrial fibrillation – developed with the Abnormal atrial repolarization and depolarization contribute to the inducibility special contribution of the European Heart Rhythm Association. Europace of atrial fibrillation in Brugada syndrome. Int Heart J 2010;51:159–65. 2012;14:1385–413. 15. Chen Q, Kirsch GE, Zhang D, Brugada R, Brugada J, Brugada P et al. Genetic 7. Yamada T, Yoshida Y, Tsuboi N, Murakami Y, Okada T, McElderry HT et al. basis and molecular mechanism for idiopathic ventricular fibrillation. Nature Efficacy of pulmonary vein isolation in paroxysmal atrial fibrillation patients with 1998;392:293–6. a Brugada electrocardiogram. Circ J 2008;72:281–6. 16. Calloe K, Cordeiro JM, Di Diego JM, Hansen RS, Grunnet M, Olesen SP et al.A 8. Conte G, Chierchia GB, Wauters K, De Asmundis C, Sarkozy A, Levinstein M transient outward potassium current activator recapitulates the electrocardio- et al. Pulmonary vein isolation in patients with Brugada syndrome and atrial fibril- graphic manifestations of Brugada syndrome. Cardiovasc Res 2009;81:686–94. lation: a 2-year follow-up. Europace 2014;16:528–32. 17. Miyazaki S, Taniguchi H, Kusa S, Komatsu Y, Ichihara N, Takagi T et al. Catheter 9. Kitamura T, Fukamizu S, Kawamura I, Hojo R, Aoyama Y, Komiyama K et al. ablation of atrial tachyarrhythmias causing inappropriate implantable Long-term efficacy of catheter ablation for paroxysmal atrial fibrillation in cardioverter-defibrillator shocks. Europace 2015;17:289–94. Erratum doi:10.1093/europace/euy033 .................................................................................................................................................... Erratum to: Use of leadless pacemakers in Europe: results of the European Heart Rhythm Association survey [Europace 2018;20:555–9]. This paper has been corrected online and in print to add an acknowledgement: ‘This document is supported by Medtronic in the form of an educational grant. The content has not been influenced in any way by its sponsor.’ The Publisher apologises for this error. Published on behalf of the European Society of Cardiology. All rights reserved.V The Author(s) 2018. For permissions, please email: journals.permissions@oup.com. Downloaded from https://academic.oup.com/europace/article-abstract/20/3/554/4862498 by Ed 'DeepDyve' Gillespie user on 16 March 2018

Journal

EuropaceOxford University Press

Published: Mar 1, 2018

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial